☆ 3.8 Article

Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure

VALUE IN HEALTH REGIONAL ISSUES (2024)

Related references

Note: Only part of the references are listed.

Article Computer Science, Information Systems

Quantifying the impact of COVID-19 on essential health services: a comparison of interrupted time series analysis using Prophet and Poisson regression models

William Ogallo et al.

Summary: This study compared interrupted time series analysis using Prophet and Poisson regression models to evaluate the impact of COVID-19 on essential health services in sub-Saharan African countries. The results showed that both models generated similar estimates of the impact of COVID-19 on most outcome-region pairs, but there were differences in some regions. Therefore, rigor and multimethod triangulation are necessary to study the true effect of pandemics on essential health services.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Future burden of cardiovascular disease in Australia: impact on health and economic outcomes between 2020 and 2029

Clara Marquina et al.

Summary: The study estimated the health and economic burden of cardiovascular disease in Australia from 2020 to 2029, finding a significant impact in terms of morbidity, mortality, healthcare costs, and productivity losses. The model projected a high number of fatal and non-fatal cardiovascular events, with a substantial number of Australians expected to have prevalent cardiovascular disease by 2029. The total cost of cardiovascular disease, including healthcare costs and productivity losses, was projected to exceed a significant amount in Australian dollars.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Article Economics

Trajectories of prices in generic drug markets: what can we infer from looking at trajectories rather than average prices?

Antonio J. Trujillo et al.

Summary: This paper examines the price trajectories of generic drugs using a group-based trajectory modelling approach. The results show that most generic drugs have slow or rapid price declines, while around 17% of them have rapid price increases. Based on these findings, the paper discusses which drugs would be most likely affected by the law currently being considered by Congress regarding excise tax on drugs with excessive price increases.

HEALTH ECONOMICS REVIEW (2022)

Add to Collection

Review Medicine, General & Internal

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Roger Chou et al.

Summary: Statin therapy for primary prevention of cardiovascular disease is associated with reduced risk of all-cause mortality and cardiovascular events. There is no significant increase in the risk of adverse events.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Multidisciplinary Sciences

Gazing through time and beyond the health sector: Insights from a system dynamics model of cardiovascular disease in Australia

Cindy Q. Peng et al.

Summary: In Australia, improving system response to acute cardiovascular events can greatly reduce cardiovascular disease-related deaths, while strategies targeting the environment supporting healthy lifestyles are effective in reducing both hospitalizations and deaths, as well as producing societal economic benefits.

PLOS ONE (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Statins Do More Than Lower Cholesterol-Depending on What You Eat?

Thomas Eschenhagen et al.

CIRCULATION (2021)

Add to Collection

Article Peripheral Vascular Disease

STATIN THERAPY IS ASSOCIATED WITH BETTER 24-HOUR AND NIGHT-TIME BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS

Francesco Spannella et al.

JOURNAL OF HYPERTENSION (2021)

Add to Collection

Article Medicine, General & Internal

Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018

Shuo-yu Lin et al.

Summary: The study found that full generic competition of statins was associated with significant cost savings across all major payers within the US health care system.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Health Care Sciences & Services

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation

Veronique C. Raimond et al.

Summary: The United States spends more on prescription drugs per capita compared to France due to differences in managing drug prices and global health budgets. Linking drug prices to value is key in controlling spending.

MILBANK QUARTERLY (2021)

Add to Collection

Article Medicine, General & Internal

Evolving worldwide approaches to lipid management and implications for Australian general practice

Tom Brett et al.

Australian Journal of General Practice (2021)

Add to Collection

Article Health Care Sciences & Services

The Evolution of Supply and Demand in Markets for Generic Drugs

Richard G. Frank et al.

Summary: Concerns have arisen in recent policy debates about generic drug markets, with changes in regulations, purchasing structure, and drug supply chains affecting market dynamics. While effective price competition remains in larger markets, smaller markets and injectable products face less competition and more supply disruptions. The image of generic drugs as a commodity in competitive markets is simplistic, with increasing evidence of price spikes, sustained high margins, and market instabilities.

MILBANK QUARTERLY (2021)

Add to Collection

Review Medicine, General & Internal

Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses

Ting Cai et al.

Summary: This study aimed to assess the associations between statins and adverse events in primary prevention of cardiovascular disease, while also examining how these associations varied by type and dosage of statins. The findings suggest that the benefits of statins in preventing cardiovascular disease generally outweigh the risks of adverse events, with little evidence to support tailoring the type or dosage of statins based on safety concerns.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Strategies to achieve fairer prices for generic and biosimilar medicines

Alessandra Ferrario et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Review Medicine, General & Internal

ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease

Cara Reiter-Brennan et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease

Martin Bodtker Mortensen et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study

Gregory A. Roth et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Autonomy, power dynamics and antibiotic use in primary healthcare: A qualitative study

Laura Medina-Perucha et al.

PLOS ONE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease

Martin Bodtker Mortensen et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Review Medicine, General & Internal

Medication adherence influencing factors-an (updated) overview of systematic reviews

Alina Gast et al.

SYSTEMATIC REVIEWS (2019)

Add to Collection

Article Multidisciplinary Sciences

Estimating the future health and aged care expenditure in Australia with changes in morbidity

Anthony Harris et al.

PLOS ONE (2018)

Add to Collection

Review Public, Environmental & Occupational Health

Effectiveness of programs to promote cardiovascular health of Indigenous Australians: a systematic review

Vainess Mbuzi et al.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2018)

Add to Collection

Review Multidisciplinary Sciences

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

Toon van der Gronde et al.

PLOS ONE (2017)

Add to Collection

Article Health Care Sciences & Services

Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme

Jonathan Karnon et al.

AUSTRALIAN HEALTH REVIEW (2017)

Add to Collection

Article Public, Environmental & Occupational Health

A Comparison of Statin Therapies in Hypercholesterolemia in Women: A Subgroup Analysis of the STELLAR Study

Francine K. Welty et al.

JOURNAL OF WOMENS HEALTH (2016)

Add to Collection

Article Oncology

Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

Sabine Vogler et al.

LANCET ONCOLOGY (2016)

Add to Collection

Article Health Care Sciences & Services

Cost driver analysis of statin expenditure on Australia's Pharmaceutical Benefits Scheme

L. P. Thai et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2016)

Add to Collection

Article Health Care Sciences & Services

Generic drug prices and policy in Australia: room for improvement? A comparative analysis with England

Sarah J. Mansfield

AUSTRALIAN HEALTH REVIEW (2014)

Add to Collection

Review Pharmacology & Pharmacy

The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use

Mohamed Azmi Hassali et al.

SAUDI PHARMACEUTICAL JOURNAL (2014)

Add to Collection

Article Health Care Sciences & Services

Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy

Jean Spinks et al.

AUSTRALIAN HEALTH REVIEW (2013)

Add to Collection

Editorial Material Medicine, General & Internal

Challenges and opportunities for the Pharmaceutical Benefits Scheme

Philip M. Clarke

MEDICAL JOURNAL OF AUSTRALIA (2012)

Add to Collection

Article Medicine, General & Internal

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Philip M. Clarke et al.

MEDICAL JOURNAL OF AUSTRALIA (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.